These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 32581239)
1. mTOR and S6K1 drive polycystic kidney by the control of Afadin-dependent oriented cell division. Bonucci M; Kuperwasser N; Barbe S; Koka V; de Villeneuve D; Zhang C; Srivastava N; Jia X; Stokes MP; Bienaimé F; Verkarre V; Lopez JB; Jaulin F; Pontoglio M; Terzi F; Delaval B; Piel M; Pende M Nat Commun; 2020 Jun; 11(1):3200. PubMed ID: 32581239 [TBL] [Abstract][Full Text] [Related]
2. FMRP S499 is phosphorylated independent of mTORC1-S6K1 activity. Bartley CM; O'Keefe RA; Bordey A PLoS One; 2014; 9(5):e96956. PubMed ID: 24806451 [TBL] [Abstract][Full Text] [Related]
3. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Roux PP; Ballif BA; Anjum R; Gygi SP; Blenis J Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13489-94. PubMed ID: 15342917 [TBL] [Abstract][Full Text] [Related]
4. Arginase-II activates mTORC1 through myosin-1b in vascular cell senescence and apoptosis. Yu Y; Xiong Y; Montani JP; Yang Z; Ming XF Cell Death Dis; 2018 Feb; 9(3):313. PubMed ID: 29472548 [TBL] [Abstract][Full Text] [Related]
5. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. Jaeschke A; Hartkamp J; Saitoh M; Roworth W; Nobukuni T; Hodges A; Sampson J; Thomas G; Lamb R J Cell Biol; 2002 Oct; 159(2):217-24. PubMed ID: 12403809 [TBL] [Abstract][Full Text] [Related]
6. Critical role of T-loop and H-motif phosphorylation in the regulation of S6 kinase 1 by the tuberous sclerosis complex. Shah OJ; Hunter T J Biol Chem; 2004 May; 279(20):20816-23. PubMed ID: 14993219 [TBL] [Abstract][Full Text] [Related]
7. The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex. Zhang B; Zou J; Han L; Beeler B; Friedman JL; Griffin E; Piao YS; Rensing NR; Wong M Epilepsia; 2018 Sep; 59(9):1796-1806. PubMed ID: 30079598 [TBL] [Abstract][Full Text] [Related]
9. Multisite Phosphorylation of S6K1 Directs a Kinase Phospho-code that Determines Substrate Selection. Arif A; Jia J; Willard B; Li X; Fox PL Mol Cell; 2019 Feb; 73(3):446-457.e6. PubMed ID: 30612880 [TBL] [Abstract][Full Text] [Related]
10. Rapamycin and dexamethasone during pregnancy prevent tuberous sclerosis complex-associated cystic kidney disease. Nechama M; Makayes Y; Resnick E; Meir K; Volovelsky O JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32484794 [TBL] [Abstract][Full Text] [Related]
11. Carbonic Anhydrase 2 Deletion Delays the Growth of Kidney Cysts Whereas Foxi1 Deletion Completely Abrogates Cystogenesis in TSC. Barone S; Zahedi K; Brooks M; Soleimani M Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731991 [TBL] [Abstract][Full Text] [Related]
12. Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt. Kenerson HL; Subramanian S; McIntyre R; Kazami M; Yeung RS PLoS One; 2015; 10(2):e0117000. PubMed ID: 25646773 [TBL] [Abstract][Full Text] [Related]
13. Genetic Etiologies, Diagnosis, and Treatment of Tuberous Sclerosis Complex. Salussolia CL; Klonowska K; Kwiatkowski DJ; Sahin M Annu Rev Genomics Hum Genet; 2019 Aug; 20():217-240. PubMed ID: 31018109 [TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760 [TBL] [Abstract][Full Text] [Related]
15. Renal disease in tuberous sclerosis complex: pathogenesis and therapy. Lam HC; Siroky BJ; Henske EP Nat Rev Nephrol; 2018 Nov; 14(11):704-716. PubMed ID: 30232410 [TBL] [Abstract][Full Text] [Related]
16. Phosphorylated mTORC1 represses autophagic-related mRNA translation in neurons exposed to ischemia-reperfusion injury. Hua R; Wei H; Liu C; Shi Z; Xing Y J Cell Biochem; 2019 Sep; 120(9):15915-15923. PubMed ID: 31081172 [TBL] [Abstract][Full Text] [Related]
17. Early dietary restriction in rats alters skeletal muscle tuberous sclerosis complex, ribosomal s6 and mitogen-activated protein kinase. Calkins KL; Thamotharan S; Dai Y; Shin BC; Kalhan SC; Devaskar SU Nutr Res; 2018 Jun; 54():93-104. PubMed ID: 29685622 [TBL] [Abstract][Full Text] [Related]
18. Turnover of the active fraction of IRS1 involves raptor-mTOR- and S6K1-dependent serine phosphorylation in cell culture models of tuberous sclerosis. Shah OJ; Hunter T Mol Cell Biol; 2006 Sep; 26(17):6425-34. PubMed ID: 16914728 [TBL] [Abstract][Full Text] [Related]
19. A novel TSC1 frameshift mutation c.1550_1551del causes tuberous sclerosis complex by aberrant splicing and nonsense-mediated mRNA degradation (NMD) simultaneously in a Chinese family. Qiu C; Li C; Tong X; Dai L; Liu W; Xie Y; Zhang Q; Yang G; Li T Mol Genet Genomic Med; 2020 Oct; 8(10):e1410. PubMed ID: 32735081 [TBL] [Abstract][Full Text] [Related]
20. EPRS is a critical mTORC1-S6K1 effector that influences adiposity in mice. Arif A; Terenzi F; Potdar AA; Jia J; Sacks J; China A; Halawani D; Vasu K; Li X; Brown JM; Chen J; Kozma SC; Thomas G; Fox PL Nature; 2017 Feb; 542(7641):357-361. PubMed ID: 28178239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]